HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (2)
2022
-
MRI for Evaluation of Complications of Breast Augmentation
Radiographics, Vol. 42, Núm. 4, pp. 929-946
2015
-
Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer
Current Medical Research and Opinion, Vol. 31, Núm. 6, pp. 1129-1137